scholarly journals Current Status of Educational Experience and Preferred Educational and Certification Program of Clinical Research Nurses: A Questionnaire Survey

Author(s):  
Ihnsook Jeong ◽  
Hyun-Sook Kang ◽  
Won-Ock Kim
2004 ◽  
Vol 29 (3) ◽  
pp. 201-215 ◽  
Author(s):  
Hiroshi MINESHIMA ◽  
Yoshihiko ENDO ◽  
Hiroyuki OGASAWARA ◽  
Keiji NISHIGAKI ◽  
Toshiaki NUMA ◽  
...  

2007 ◽  
Vol 0 (0) ◽  
pp. 070621074500021-??? ◽  
Author(s):  
Karen Spilsbury ◽  
Emily Petherick ◽  
Nicky Cullum ◽  
Andrea Nelson ◽  
Jane Nixon ◽  
...  

2020 ◽  
Vol 54 (6) ◽  
pp. 1461-1472
Author(s):  
L. Horavova ◽  
K. Nebeska ◽  
L. Souckova ◽  
R. Demlova ◽  
P. Babula

Abstract Introduction Paediatric non-commercial interventional clinical trials (NICTs) are crucial for healthcare provision. In spite of the fact that current regulations and initiatives try to enhance the quantity and quality of paediatric NICTs, there are still shortcomings that need to be addressed in order to accelerate the conduct of relevant clinical trials in children. To improve the current landscape of paediatric clinical research, it is necessary to identify and analyse the main trends and shortcomings, along with their impact on national performance in paediatric NICTs and this is the aim of this work. Method A retrospective systematic search of paediatric NICTs was performed on four international clinical trials registries. Entries were filtered by date from 01/01/2004 to 31/12/2017. Each identified paediatric NICT was screened and analysed for sponsors, funders, type of intervention, therapeutic area, design characteristics and associated publications. Results The search identified 439 unique NICTs. When stratifying the trials by enrolment ages, 86 trials were found involving the paediatric population. Most trials investigated the use of medicinal products and were focused on cancer or cardiovascular diseases. The most common sources of the funding were non-profit organizations. Furthermore, from the total number of completed trials, only half of them already published their results. Conclusion The main shortcomings—specifically, ethical, methodological and, in particular, economic obstacles were identified. There is a continual need for greater support and collaboration between all major stakeholders including health policymakers, grant agencies, research institutions, pharmaceutical industries and healthcare providers at the national and international level.


2018 ◽  
Vol 27 (5-6) ◽  
pp. e787-e797 ◽  
Author(s):  
Fabio Zucchelli ◽  
Nichola Rumsey ◽  
Kerry Humphries ◽  
Rhiannon Bennett ◽  
Amy Davies ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document